Abstract
BackgroundCurrent guideline for gout recommends the use of allopurinol or febuxostat in moderate-to-severe chronic kidney disease (CKD). However, the appropriate febuxostat dosage required to attain the target serum urate (SU)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
